The “Grand Slam” Cancer Claim Meets Math with Dr Robert Hoffman

Send us Fan Mail A cancer drug gets FDA approval and the biggest voices in oncology call it a “grand slam.” We’re not here to dunk on new treatments, we’re here to read the chart. Joe Grumbine sits down with Dr. Robert Hoffman, a research scientist who has spent decades studying methionine dependence in cancer, to ask what the trial results actually say about pancreatic cancer survival, progression-free survival, and the real cost of side effects when families are desperate for hope. From th...